Introduction
Production of colostrum and milk in adequate quantities is essential for the survival of the young of most mammals. Preparation of the mammary gland for lactation takes place throughout fetal and post-natal life and results from many complex interactions. It involves the transformation of the gland from an epithelial anlagen in the fetus, through formation of a branched tubular structure to the fully developed lobulo-alveolar gland which has acquired the differentiated capacity to produce milk proteins, fat and sugar and, by milk ejection, to deliver these to the suckling. Mammary development has been reviewed extensively (see Cowie et al., 1980; Mepham, 1983;  Knight, 1984; Tucker, 1987 , for recent reviews and further references).
The yield of the mammary gland is determined by numbers of epithelial cells and by their ability to transport, synthesize and secrete milk components. The balance between cell number and the secretory capacity of cells or alveolar units determines the shape of the lactation curve (Knight & Wilde, 1987) . This is in part determined by systemic endocrine factors but it is increasingly evident that there is a large measure of local control.
Methods of study
Many methodologies have been used to study the mammary gland. The stimulus has been both interest in lactation as part of the reproductive cycle and also the relative accessibility of mammary tissue. Because much of its development occurs into adult life, the mammary gland is an excellent model for the cell biology of normal and neoplastic growth and of differentiation.
Endocrine organ ablation and replacement therapy
This has been the classical approach to the study of mammary development. It has established the importance of hormones from the ovary, adrenal, pituitary and placenta acting systemically in bringing about the different phases of mammary growth and function. Sequential administration of combinations of steroid and protein hormones can mimic the development occurring through puberty, first pregnancy and into lactation in rats (Lyons, 1958) and mice (Nandi, 1959) that have been ovariectomized, adrenalectomized and hypophysectomized. The number of species in which it is practicable to apply such methods is, however, strictly limited and it is not possible to con¬ clude whether hormones are acting directly, or indirectly via hormone-dependent factors produced in the mammary gland or another tissue. One of the concerns in earlier studies of this type was whether the metabolic status of endocrinectomized animals was adequately restored (Jacobsohn, 1961) .
Transplantation
Studies in mice have shown that mammary epithelium can be transplanted into mammary fat pads previously cleared by destruction of the mammary rudiment (DeOme et al, 1959) or into other subcutaneous or intra-abdominal fat deposits (Hoshino & Martin, 1974 (Soule & McGrath, 1980; McManus & Welsch, 1984) and bovine (Sheffield & Welsch, 1986 ) mammary tissue have been studied by this method.
Local hormone administration
Test materials can be applied directly to mammary tissue in vivo to study local effects. Methods which have been used include local injection either subcutaneously over the gland or into the gland via the teat (Lyons, 1942) and the use of slow release implants (Silberstein & Daniel, 1987) .
Culture in vitro
The ability to sustain growth and development of mammary tissue in culture in defined con¬ ditions has provided a powerful tool in the study of regulation. The mouse mammary gland was one of the first organs to be successfully cultured, as expiants, in serum-free conditions (Rivera & Bern, 1961) in medium supplemented with insulin + cortisol for optimal survival, plus prolactin (and/or growth hormone in the original studies) to induce or maintain secretory activity.
Perhaps closest to the in-vivo situation in that normal relationships between epithelium and stroma are maintained in full is the culture of whole glands, within the mammary fat pad (Ichinose & Nandi, 1966; Banerjee & Antoniou, 1984 (Emerman et al, 1977) . Proliferation of epithelial cells can also be studied on attached collagen gels before confluence is attained (Mackenzie et al, 1982) and by embedding cells in collagen when branching duct-like structures form (Yang et al, 1980; Imagawa et al, 1982; McGrath, 1987) . Other recently developed methods include the use of feeder layers of 3T3-L1 adipocytes (Levine & Stockdale, 1984) and extracellular matrix extracted from mammary tissue (Wicha et al, 1982) . These studies emphasize the requirements of mammary tissue for cell-cell interactions and for an appropriate substratum, reconstructing the in-vivo association between epithelium and stroma. Insoluble components of the extracellular matrix (laminin, type IV collagen, heparan sulphate proteoglycan; see Parry et al, 1987) and diffusible paracrine growth factors (see Oka & Yoshimura, 1986) (Hammond et al, 1984 ; see also Bettgar & McKeehan, 1986 (Lee et al, 1984 (Forsyth, 1986; Thordarson & Talamantes, 1987) . Thyroid hormones regulate lobulo-alveolar development in the mouse (Vonderhaar & Greco, 1979) . There are species differences in requirements, especially for the maintenance of lactation. In ruminants, growth hormone, rather than prolactin, plays the dominant role (Johnsson & Hart, 1986; Peel & Bauman, 1987) . Forsyth, 1983; Akers, 1985) .
In considering differentiation, the action of hormones on the mammary gland appears to be largely direct. Prolactin plays a major role in activating transcription and translation of milk pro¬ tein genes and the stabilization of messenger RNA. Glucocorticoids enhance the action of prolactin on transcription (see Houdebine et al, 1985; Rosen, 1987) . Thyroid hormones synergize with pro¬ lactin with respect to a-lactalbumin synthesis (see Topper & Freeman, 1980) . Insulin is essential for transcription of mouse and rat casein messenger RNA (Bolander et al, 1981; Chomczynski et al, 1984) but insulin-like growth factors can substitute in other roles, which require supraphysiological insulin concentrations in vitro (see below for further discussion).
To reconcile in-vivo and in-vitro findings on the biological actions of GH, Salmon & Daughaday (1957) (1987) have proposed the 'synlactin' hypothesis, suggesting that the growthpromoting actions of prolactin may result from a synergism between prolactin itself and prolactindependent synlactins produced by the liver and perhaps other tissues. They have demonstrated that media conditioned by liver slices from pregnant and lactating rats, but not male or virgin female rats, increase DNA synthesis in rat mammary expiants.
To explore the apparent failure of oestrogen-responsive tumours to show increase in cell number in response to oestradiol in vitro, Sirbasku (1978) proposed the 'estromedin' hypothesis. Oestrogen-dependent factors which stimulated proliferation of mammary tumour cells were present in extracts of various rat tissues but the physiological significance of endocrine, oestrogeninduced mitogens remains to be determined. A major pituitary-derived mitogen has been identified as transferrin, that is an essential cell nutrient rather than a growth factor (Riss & Sirbasku, 1987) . At least part of the failure to detect mitogenic effects of oestradiol has been due to the almost ubiquitous use of phenol red as a pH indicator in culture medium. Berthois et al. (1986) showed that it acts as a weak oestrogen, mimicking, or masking, the mitogenic effects of added oestrogens. In phenol red-free medium, effects of oestradiol on DNA synthesis and cell proliferation can be observed (Table 2 ). Nevertheless, demonstration of an effect of oestradiol on cell proliferation in vitro does not provide proof that the hormone is acting directly. Acting via its receptor it might stimulate the release of an autocrine growth factor (Dickson et al, 1986) . The possibility that oestrogens release target cells from inhibitory control has also been considered (Soto & Sonnenschein, 1987) . The actions of GH on mammary growth and function are complex. Extensive studies of milk yield stimulation by recombinant GH in cattle (see Peel & Bauman, 1987) indicate co-ordinated changes in many tissues. Actions at the mammary gland itself may well involve the insulin-like growth factors. Presser et al. (1988) have shown that local infusion of IGF-I into goat mammary gland leads to increased milk secretion and mammary blood flow.
Experimental evidence of growth factor effects on mammary gland Several putative uncharacterized growth factors for normal and neoplastic mammary cells have been proposed on the basis of activities present in tissue extracts and conditioned medium. These have been derived from non-mammary tissues, including pituitary and liver (endocrine) and from the mammary gland itself (paracrine or autocrine, associated respectively with mammary mesenchyme or epithelium (see Oka & Yoshimura, 1986) al, 1979) and transferrin from pig pituitaries (Riss & Sirbasku, 1987) . Beck & Hosick (1988) Kidwell et al, 1982) .
The alternative approach has been to examine the effects of purified or synthesized growth factors on mammary growth and differentiation. In some instances, generally with tumour cells, the two approaches have come together and it has been possible to identify active agents as known or new growth factors.
Insulin-like growth factors
The insulin-like growth factors (IGFs) form part of a family of structurally-related peptides which also includes proinsulin and relaxin (Blundell & Humbel, 1980) . They are potent mitogens for many cells. Human IGF-I is a basic polypeptide of 70 amino acid residues and is GHdependent. IGF-II, which shows much less GH dependence, is a neutral polypeptide of 67 amino acids. The structure of IGFs has been highly conserved (Daughaday et al, 1987) . In circulation, IGFs are bound non-covalently to large molecular weight binding proteins. Predominant roles for IGF-I after birth and for IGF-II in the fetus have been postulated (Adams et al, 1983) . 54-2 + 6-7 10 99-3 ± 8-5 100 126-2 + 4-6
Receptors for IGFs are of two types. The type 1 receptor is a heterotetramer, structurally homologous with the insulin receptor. It has a higher affinity for IGF-I than IGF-II and a low affinity for insulin. The type 2 receptor is a monomer, has a higher affinity for IGF-II than IGF-I and no significant affinity for insulin (Massagué & Czech, 1982) . Binding of IGF-I with the charac¬ teristics of type 1 receptor has been detected in bovine (Campbell & Baumrucker, 1986) and ovine (Winder & Forsyth, 1987; Disenhaus et al, 1988 ) mammary gland. IGF-II binding has also been detected in ovine mammary gland, receptor numbers being greater than for IGF-I (Disenhaus et al, 1988) . Breast cancer cell lines show receptors for both IGF-I and IGF-II and these appear similar in structure to the type 1 and type 2 receptors of other tissues (Furlanetto & DiCarlo, 1984; Myal et al, 1984; DeLeon et al, 1988) .
Mitogenic effects of IGF-I have been shown in cultures of normal mammary cells and breast cancer cell lines. Sheep mammary cells grown in phenol red-containing medium on attached collagen gels respond to IGF-I over the dose range 1-100 ng/ml and do not require the presence of any other added mitogen to produce this effect (Winder & Forsyth, 1986;  Table 3 ). Mouse mammary epithelial cells in collagen increase cell number in response to IGF-I, but epidermal growth factor (EGF) is also required (Imagawa et al, 1986) . IGF-I stimulates DNA synthesis in human breast cancer cell lines in vitro (Furlanetto & DiCarlo, 1984; Myal et al, 1984) , as well as tumour formation by human MCF-7 cells in vivo in athymic mice (Dickson et al, 1986 ).
Sheep mammary cells show little response to IGF-II in vitro (Winder & Forsyth, 1986) but the T-47D human breast cancer cell line grows in response to rat IGF-II (Myal et al, 1984 (Dembinski & Shiu, 1987) .
Human breast cancer cell lines synthesize and secrete IGF-I. This has been demonstrated by radioimmunoassay, partial purification and the presence of messenger RNAs (see Dickson & Lippman, 1987) . Messenger RNA for IGF-I but not IGF-II has been demonstrated at low levels in normal rat mammary gland (Murphy et al, 1987) . Oestradiol and insulin stimulate IGF-I production in MCF-7 cells in phenol red-free media (Dickson & Lippman, 1987) .
Some of the reported effects of insulin on mammary tissue may be mediated via cross-reaction with the type 1 receptor. This would explain the supraphysiological concentrations of insulin (~10~6m) which are generally found to be necessary to stimulate cell replication in mammary expiants (Stockdale et al, 1966; Skarda et al, 1977) and to potentiate maximally the effects of prolactin on lactogenesis in vitro (Houdebine et al, 1985) . It would also explain why diabetic animals show no significant impairment of mammary growth (Norgren, 1968; Topper & Freeman, 1980) . In addition to effects on cell replication, Prosser & Topper (1986) (Posner et al, 1974; Campbell et al, 1987 (Bolander et al, 1981; Chomczynski et al, 1984) .
Epidermal growthfactor (EGF)
Extraction of mouse submaxillary gland and of human urine led independently to the purifi¬ cation of two polypeptides, mouse EGF and urogastrone, respectively. Structural studies showed them to be homologous, with 53 amino acid residues. A variety of biological activities has been demonstrated for EGF and it is widely distributed among species (Hollenberg, 1979) .
Most of the evidence of a role for epidermal growth factor in mammary development comes from studies in the mouse. Receptors for EGF have been detected in normal mouse mammary gland (Taketani & Oka, 1983a) and shown to vary with physiological state (Edery et al, 1985) . One class of specific high affinity receptors for EGF "11 m) was detected in dissociated mammary epithelial cells from virgin mice and in membrane fractions. A second class of high affinity receptors (Ä^d 5 10 m), seen only in mammary gland membrane fractions, may be associated with stroma. From weaning there was a decline in levels of receptor binding with increasing age to the lowest levels in lactation, but with a marked increase between Days 5 and 10 of pregnancy, roughly paralleling the proliferative activity of the gland. Thyroid hormone and progesterone (Murphy et al, 1988) (Tonelli & Sorof, 1980 and fibroblast feeder layers (Stoker et al, 1976; Taylor-Papadimitriou et al, 1977; Taketani & Oka, 1983a, b; Imagawa et al, 1986) . In vivo, the local implantation of EGF stimulates lobulo-alveolar development of mouse mammary gland in oestrogen-progesterone-primed mice (Vonderhaar, 1987; Silberstein & Daniel, 1987) . The incidence of tumour development from MCF-7 cells implanted into athymic ovariectomized mice was increased by EGF administration (Dickson et al, 1986 ).
In addition to the positive effects on proliferation, EGF may affect functional differentiation of mammary gland. Taketani & Oka (1983a) (Vonderhaar & Nakhasi, 1986) . In the presence of insulin, aldosterone and corticosterone, EGF increased messenger RNA for ß-and -casein in expiants of mammary gland from pregnant mice. In rats only -casein mRNA was affected. When prolactin was also present, EGF became inhibi¬ tory to casein gene expression in tissues from pregnant and virgin rats and mice. However, Sankaran & Topper (1987) (Salomon et al, 1981 (Salomon et al, 1984; Zwiebeleí al, 1986) and in bovine mammary epithelium (Eckert étal, 1985) .
A local effect of TGF-on lobulo-alveolar development in virgin female mice is reported by Vonderhaar (1987) . The response was similar to that produced by EGF but the gland was more sensitive to TGF-, which acted at lower dose levels and in the absence of exogenous oestrogen/ progesterone priming. Stimulation of TGF-production by oestradiol occurs in breast cancer cell lines (Dickson & Lippman, 1987) . There is some evidence from in-vivo studies supporting a role for EGF in mammary growth. Okamato & Oka ( 1984) found that removal of the submandibular salivary glands (sialoadenectomy) of virgin mice impaired their subsequent ability to raise large litters. Sheffield & Welsch (1987) observed reduced mammary development and a reduced response to oestrogen + progesterone treatment in sialoadenectomized mice, effects which could be partly reversed by grafts of sub¬ mandibular salivary gland or injection of EGF. Circulating plasma EGF shows circadian variation and is higher between 24:00 and 08:00 h in intact pregnant and lactating mice than in virgin mice. The elevation persists after the young are weaned and is abolished by sialoadenectomy (Kurachi & Oka, 1985; Sheffield & Welsch, 1987) . However, sialoadenectomy does not alter urinary EGF concentrations (Kurachi & Oka, 1985) .
Other growth factors A group of growth factors has been recognized, all with a strong affinity for heparin and includ¬ ing factors which stimulate angiogenesis. Two sub-classes have been identified: Class 1 anionic mitogens, including acidic brain fibroblast growth factor (FGF), molecular weight 15 000-17 000, and Class 2 cationic mitogens including basic pituitary FGF, molecular weights 18 000-20 000 (Lobb et al, 1986) . Bovine pituitary FGF stimulated the growth of cloned rat mammary myo¬ epithelial and stromal cell lines in culture (Smith et al, 1984) and also T-47D human breast cancer cells (Dembinski & Shiu, 1987) . Rowe et al (1986) have purified a related growth factor from human mammary tumour.
An activity related to platelet-derived growth factor (PDGF) is secreted by many breast cancer cell lines, although they appear not to contain a PDGF receptor (Dickson & Lippman, 1987) . PDGF is the major growth factor in serum, derived from platelets and is a heterodimer of a 14 000-18 000 molecular weight A chain and a 16 000 molecular weight chain. It is a potent mitogen for mesenchymal cells (Deuel et al, 1987) . Baño et al. (1985) have identified in human mammary tumours and milk a growth factor (mammary-derived growth factor-1, MDGF-1) which has properties distinguishing it from other known growth factors. It has a molecular weight of 62 000 and a pi of [4] [5] [6] [7] [8] (Read, 1988) . There are considerable differences between species in the presence, or concentration, of milk growth factors. In human and mouse milk, EGF is the major mitogen and EGF concentrations in human milk are many times higher than in plasma (Carpenter, 1980) . In ruminant milk, EGF could not be detected and the major growth factor activity is colostric basic growth factor, structurally related to PDGF (Brown & Blakeley, 1984) . Other growth factors identified in milk include IGF-I and TGF-(see Read, 1988, for (Rail et al, 1985; Murphy et al, 1987) 
